Trial intelligence / Profile preview

Different tranexamic acid delivery methods in posterior spinal surgery

ChiCTR1900026196Phase 4Recruiting

Sponsor
Xi'an Honghui Hospital
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of tranexamic acid and bupivacaine in Back disorder (11 arms), sponsored by Xi'an Honghui Hospital. Primary endpoints: Blood loss, Hemoglobin and 7 more. Started Sep 2019; status: recruiting.

02

Drugs

tranexamic acidbupivacaine
03

Conditions

Back disorder

Beyond the preview

Go deeper on ChiCTR1900026196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call